BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 30960288)

  • 21. Clarithromycin-Loaded Poly (Lactic-
    Öztürk AA; Yenilmez E; Özarda MG
    Polymers (Basel); 2019 Oct; 11(10):. PubMed ID: 31600969
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chitosan-Coated PLGA Nanoparticles Loaded with
    Azzazy HME; Fahmy SA; Mahdy NK; Meselhy MR; Bakowsky U
    Nanomaterials (Basel); 2021 Sep; 11(9):. PubMed ID: 34578755
    [TBL] [Abstract][Full Text] [Related]  

  • 23. PTX-loaded three-layer PLGA/CS/ALG nanoparticle based on layer-by-layer method for cancer therapy.
    Wang F; Yuan J; Zhang Q; Yang S; Jiang S; Huang C
    J Biomater Sci Polym Ed; 2018 Sep; 29(13):1566-1578. PubMed ID: 29749303
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Improved oral delivery of insulin by PLGA nanoparticles coated with 5
    Wang W; Yu C; Zhang F; Li Y; Zhang B; Huang J; Zhang Z; Jin L
    Biomed Mater; 2021 Oct; 16(6):. PubMed ID: 34571498
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CS/PAA@TPGS/PLGA nanoparticles with intracellular pH-sensitive sequential release for delivering drug to the nucleus of MDR cells.
    Wang YY; Zhang DD; Kong YY; Shao LL; Zhang FY; Gao Y; Mu X; Wang J; Li HF; Yu SQ; Xu Q
    Colloids Surf B Biointerfaces; 2016 Sep; 145():716-727. PubMed ID: 27289313
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Transport of PLGA nanoparticles across Caco-2/HT29-MTX co-cultured cells].
    Wen Z; Li G; Lin DH; Wang JT; Qin LF; Guo GP
    Yao Xue Xue Bao; 2013 Dec; 48(12):1829-35. PubMed ID: 24689242
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Application of temporary agglomeration of chitosan-coated nanoparticles for the treatment of lung metastasis of melanoma.
    Lee SY; Koo JS; Yang M; Cho HJ
    J Colloid Interface Sci; 2019 May; 544():266-275. PubMed ID: 30852352
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Enhancing the in vitro anticancer activity of albendazole incorporated into chitosan-coated PLGA nanoparticles.
    Kang BS; Choi JS; Lee SE; Lee JK; Kim TH; Jang WS; Tunsirikongkon A; Kim JK; Park JS
    Carbohydr Polym; 2017 Mar; 159():39-47. PubMed ID: 28038752
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Optimization and Appraisal of Chitosan-Grafted PLGA Nanoparticles for Boosting Pharmacokinetic and Pharmacodynamic Effect of Duloxetine HCl Using Box-Benkhen Design.
    Salem HF; Ali AA; Rabea YK; Abo El-Ela FI; Khallaf RA
    J Pharm Sci; 2023 Feb; 112(2):544-561. PubMed ID: 36063878
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Low molecular weight chitosan-coated polymeric nanoparticles for sustained and pH-sensitive delivery of paclitaxel.
    Abouelmagd SA; Ku YJ; Yeo Y
    J Drug Target; 2015; 23(7-8):725-35. PubMed ID: 26453168
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synthesis and Evaluation of BSA-Loaded PLGA-Chitosan Composite Nanoparticles for the Protein-Based Drug Delivery System.
    Gaur M; Maurya S; Akhtar MS; Yadav AB
    ACS Omega; 2023 May; 8(21):18751-18759. PubMed ID: 37273604
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Poly-(Lactic-co-Glycolic) Acid Nanoparticles for Synergistic Delivery of Epirubicin and Paclitaxel to Human Lung Cancer Cells.
    Sharma N; Kumari RM; Gupta N; Syed A; Bahkali AH; Nimesh S
    Molecules; 2020 Sep; 25(18):. PubMed ID: 32947799
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long-acting inhalable chitosan-coated poly(lactic-co-glycolic acid) nanoparticles containing hydrophobically modified exendin-4 for treating type 2 diabetes.
    Lee C; Choi JS; Kim I; Oh KT; Lee ES; Park ES; Lee KC; Youn YS
    Int J Nanomedicine; 2013; 8():2975-83. PubMed ID: 23976850
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Transient aggregation of chitosan-modified poly(d,l-lactic-co-glycolic) acid nanoparticles in the blood stream and improved lung targeting efficiency.
    Lee SY; Jung E; Park JH; Park JW; Shim CK; Kim DD; Yoon IS; Cho HJ
    J Colloid Interface Sci; 2016 Oct; 480():102-108. PubMed ID: 27421112
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Modeling of chitosan modified PLGA atorvastatin-curcumin conjugate (AT-CU) nanoparticles, overcoming the barriers associated with PLGA: An approach for better management of atherosclerosis.
    Dash R; Yadav M; Biswal J; Chandra A; Goel VK; Sharma T; Prusty SK; Mohapatra S
    Int J Pharm; 2023 Jun; 640():123009. PubMed ID: 37142139
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Preparation and In Vitro/Vivo Evaluation of Folate-conjugated Pluronic F87-PLGA/TPGS Mixed Nanoparticles for Targeted Drug Delivery.
    Wu T; Gong Y; Li Z; Li Y; Xiong X
    Curr Drug Deliv; 2021; 18(10):1505-1514. PubMed ID: 33845742
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intranasal delivery of Huperzine A to the brain using lactoferrin-conjugated N-trimethylated chitosan surface-modified PLGA nanoparticles for treatment of Alzheimer's disease.
    Meng Q; Wang A; Hua H; Jiang Y; Wang Y; Mu H; Wu Z; Sun K
    Int J Nanomedicine; 2018; 13():705-718. PubMed ID: 29440896
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Biodegradable Nanoparticles-Loaded PLGA Microcapsule for the Enhanced Encapsulation Efficiency and Controlled Release of Hydrophilic Drug.
    Ryu S; Park S; Lee HY; Lee H; Cho CW; Baek JS
    Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33801871
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treatment of bleomycin-induced pulmonary fibrosis by inhaled tacrolimus-loaded chitosan-coated poly(lactic-co-glycolic acid) nanoparticles.
    Lee C; Seo J; Hwang HS; Thao LQ; Lee S; Lee ES; Lee EH; Choi HG; Youn YS
    Biomed Pharmacother; 2016 Mar; 78():226-233. PubMed ID: 26898446
    [TBL] [Abstract][Full Text] [Related]  

  • 40. PLGA Microparticles Entrapping Chitosan-Based Nanoparticles for the Ocular Delivery of Ranibizumab.
    Elsaid N; Jackson TL; Elsaid Z; Alqathama A; Somavarapu S
    Mol Pharm; 2016 Sep; 13(9):2923-40. PubMed ID: 27286558
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.